AstraZeneca’s Latest Stumble Again Clouds European Vaccinations

The company defended its claims of 79 percent efficacy for its coronavirus shot and said it would release more up-to-date trial results within 48 hours.The company defended its claims of 79 percent efficacy for its coronavirus shot and said it would release more up-to-date trial results within 48 hours.Vaccination and Immunization, Coronavirus (2019-nCoV), AstraZeneca PLC, Fauci, Anthony S, United StatesRead More

Leave a Reply

Your email address will not be published.